Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

被引：30
|
作者：
Tafazoli, Alireza [1 ,2 ]
Guchelaar, Henk-Jan [3 ,4 ]
Miltyk, Wojciech [1 ]
Kretowski, Adam J. [2 ,5 ]
Swen, Jesse J. [3 ,4 ]
机构：
[1] Med Univ Bialystok, Fac Pharm, Dept Anal & Bioanal Med, Div Lab Med, Bialystok, Poland
[2] Med Univ Bialystok, Clin Res Ctr, Bialystok, Poland
[3] Leiden Univ, Dept Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands
[4] Leiden Network Personalized Therapeut, Leiden, Netherlands
[5] Med Univ Bialystok, Dept Endocrinol Diabetol & Internal Med, Bialystok, Poland
来源：
FRONTIERS IN PHARMACOLOGY | 2021年 / 12卷
基金：
欧盟地平线“2020”;
关键词：
pharmacogenomics; clinical implementation; next generation sequencing; clinical practice; PGx testing; IMPLEMENTATION CONSORTIUM; INCIDENTAL FINDINGS; CYP2D6; DRUG; GENOTYPE; CHALLENGES; EXOME; RECOMMENDATIONS; INFORMATION; MUTATIONS;
D O I：
10.3389/fphar.2021.693453
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Pharmacogenomics (PGx) studies the use of genetic data to optimize drug therapy. Numerous clinical centers have commenced implementing pharmacogenetic tests in clinical routines. Next-generation sequencing (NGS) technologies are emerging as a more comprehensive and time- and cost-effective approach in PGx. This review presents the main considerations for applying NGS in guiding drug treatment in clinical practice. It discusses both the advantages and the challenges of implementing NGS-based tests in PGx. Moreover, the limitations of each NGS platform are revealed, and the solutions for setting up and management of these technologies in clinical practice are addressed.
引用
收藏
页数：15
相关论文
共 50 条
  • [21] Next-generation sequencing in clinical microbiology
    Wain, John
    Mavrogiorgou, Eleni
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2013, 13 (03) : 225 - 227
  • [22] Review of Clinical Next-Generation Sequencing
    Yohe, Sophia
    Thyagarajan, Bharat
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (11) : 1544 - 1557
  • [23] CLINICAL APPLICATIONS OF NEXT-GENERATION SEQUENCING
    Gloria Rebollar-Vega, Rosa
    Arriaga-Canon, Cristian
    Alberto de la Rosa-Velazquez, Inti
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (04): : 153 - 157
  • [24] Next-Generation Sequencing for Clinical Diagnostics
    Jacob, Howard J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (16): : 1557 - 1558
  • [25] The Uncertainties of Clinical Next-Generation Sequencing
    Pasic, Maria D.
    CLINICAL CHEMISTRY, 2018, 64 (03) : 616 - 617
  • [26] Applying next-generation sequencing to pancreatic cancer treatment
    Mardis, Elaine R.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (08) : 477 - 486
  • [27] A Model Study of in Silico Proficiency Testing for Clinical Next-Generation Sequencing
    Duncavage, E. J.
    Merker, J. D.
    Bodner, J. B.
    Voelkerding, K. V.
    Pfeifer, J. D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 797 - 797
  • [28] Current practices and guidelines for clinical next-generation sequencing oncology testing
    Strom, Samuel P.
    CANCER BIOLOGY & MEDICINE, 2016, 13 (01) : 3 - 11
  • [29] Current practices and guidelines for clinical next-generation sequencing oncology testing
    Samuel P.Strom
    Cancer Biology & Medicine, 2016, (01) : 3 - 11
  • [30] Occult Specimen Contamination in Routine Clinical Next-Generation Sequencing Testing
    Sehn, Jennifer K.
    Spencer, David H.
    Pfeifer, John D.
    Bredemeyer, Andrew J.
    Cottrell, Catherine E.
    Abel, Haley J.
    Duncavage, Eric J.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (04) : 667 - 674
12345